Founded with the mission to revolutionize pathology workflows, SurgiVance focuses on developing advanced histopathological imaging technology. The company aims to bring rapid diagnosis to the point of care by leveraging diagnostic imaging technologies using advanced optics. Their flagship product is a line-scanning, solid-state, confocal microscope that offers enhanced speed and mechanical simplicity compared to traditional point-scanning confocal microscopes. This technology achieves cellular resolution without the complex moving parts, making it more robust and easier to manufacture.

Notable affiliated individuals include Marc Combalia, who has contributed significantly to the company's research and development efforts. SurgiVance has built a strong intellectual property portfolio and has been featured in various publications and talks, showcasing its innovative approach to medical imaging. The company's impact lies in its potential to streamline pathology workflows, reduce diagnostic times, and improve patient outcomes by providing rapid and accurate histopathological analysis at the point of care.